Changzhou Qianhong BiopharmaLTD (SZSE:002550) Shareholders Are Still up 52% Over 3 Years Despite Pulling Back 6.5% in the Past Week
Solid Earnings May Not Tell The Whole Story For Changzhou Qianhong BiopharmaLTD (SZSE:002550)
Subdued Growth No Barrier To Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) With Shares Advancing 36%
Changzhou Qianhong Biopharma CO.,LTD's (SZSE:002550) Market Cap up CN¥387m Last Week, Benefiting Both Retail Investors Who Own 49% as Well as Insiders
Investors Appear Satisfied With Changzhou Qianhong Biopharma CO.,LTD's (SZSE:002550) Prospects
Changzhou Qianhong BiopharmaLTD (SZSE:002550) Has A Pretty Healthy Balance Sheet
Changzhou Qianhong Biopharma CO.,LTD's (SZSE:002550) Has Had A Decent Run On The Stock Market: Are Fundamentals In The Driver's Seat?
Income Investors Should Know That Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Goes Ex-Dividend Soon
Investors Appear Satisfied With Changzhou Qianhong Biopharma CO.,LTD's (SZSE:002550) Prospects As Shares Rocket 26%
Changzhou Qianhong BiopharmaLTD (SZSE:002550) Shareholder Returns Have Been Decent, Earning 31% in 3 Years
Changzhou Qianhong BiopharmaLTD (SZSE:002550) Could Easily Take On More Debt
Changzhou Qianhong BiopharmaLTD (SZSE:002550) Sheds 8.8% This Week, as Yearly Returns Fall More in Line With Earnings Growth
Changzhou Qianhong Biopharma CO.,LTD's (SZSE:002550) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
Changzhou Qianhong Biopharma CO.,LTD's (SZSE:002550) Prospects Need A Boost To Lift Shares
The Total Return for Changzhou Qianhong BiopharmaLTD (SZSE:002550) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
Individual Investors Invested in Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Copped the Brunt of Last Week's CN¥410m Market Cap Decline
Does The Market Have A Low Tolerance For Changzhou Qianhong Biopharma CO.,LTD's (SZSE:002550) Mixed Fundamentals?
Changzhou Qianhong Biopharma CO.,LTD's (SZSE:002550) Market Cap Rose CN¥614m Last Week; Individual Investors Who Hold 53% Profited and so Did Insiders
Changzhou Qianhong BiopharmaLTD (SZSE:002550) Sheds 5.0% This Week, as Yearly Returns Fall More in Line With Earnings Growth
Individual Investors Who Hold 54% of Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Gained 4.9%, Insiders Profited as Well